关于《左旋多巴-卡比多巴肠凝胶治疗帕金森病患者：一项系统评价》的评论 - Suppr

Suppr

超能文献

Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".

作者信息

Lambarth Andrew T

机构信息

Faculty of Medicine, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.

出版信息

CNS Drugs. 2016 Oct;30(10):1007-8. doi: 10.1007/s40263-016-0378-8.

DOI:10.1007/s40263-016-0378-8

PMID:27541607

Abstract

摘要

相似文献

Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".

CNS Drugs. 2016 Oct;30(10):1007-8. doi: 10.1007/s40263-016-0378-8.

Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".

CNS Drugs. 2016 Oct;30(10):1009-10. doi: 10.1007/s40263-016-0379-7.

Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage.

Parkinsonism Relat Disord. 2012 Jun;18(5):686-7. doi: 10.1016/j.parkreldis.2011.11.026. Epub 2011 Dec 23.

Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.

Neurodegener Dis Manag. 2016 Jun;6(3):187-202. doi: 10.2217/nmt-2016-0011. Epub 2016 Apr 14.

The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.

Adv Ther. 2021 Jun;38(6):2854-2890. doi: 10.1007/s12325-021-01747-1. Epub 2021 May 20.

Enteral feeding in Parkinson's patients receiving levodopa/carbidopa intestinal gel.

Parkinsonism Relat Disord. 2017 Sep;42:109-111. doi: 10.1016/j.parkreldis.2017.06.015. Epub 2017 Jun 27.

Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease.

Eur J Neurol. 2012 Aug;19(8):1079-85. doi: 10.1111/j.1468-1331.2012.03679.x. Epub 2012 Feb 23.

Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.

Mov Disord. 2016 Apr;31(4):530-7. doi: 10.1002/mds.26528. Epub 2016 Jan 28.

[Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].

Neuropsychopharmacol Hung. 2015 Dec;17(4):191-6.

Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.

Neurodegener Dis Manag. 2018 Jun;8(3):161-170. doi: 10.2217/nmt-2017-0046. Epub 2018 Apr 10.

引用本文的文献

Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".

CNS Drugs. 2016 Oct;30(10):1009-10. doi: 10.1007/s40263-016-0379-7.

本文引用的文献

Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.

CNS Drugs. 2016 May;30(5):381-404. doi: 10.1007/s40263-016-0336-5.

Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients.

J Parkinsons Dis. 2015;5(1):165-74. doi: 10.3233/JPD-140456.

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20.

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

Arch Neurol. 2003 Mar;60(3):387-92. doi: 10.1001/archneur.60.3.387.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验